Agilon Health (AGL) Net Income towards Common Stockholders (2020 - 2026)

Agilon Health (AGL) has reported Net Income towards Common Stockholders for 7 consecutive years, with $19.0 million the latest figure, recorded in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $19.0 million, up 35.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.0 million (up 304.77% YoY), and the FY2025 annual result was $14.0 million, up 242.51% from the prior year.
• Net Income towards Common Stockholders was $19.0 million for Q1 2026 at Agilon Health, up from $14.0 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $19.0 million in Q1 2026 and troughed at -$47.5 million in Q4 2023.
• Average Net Income towards Common Stockholders over 5 years is -$2.3 million, with a median of -$381000.0 recorded in 2022.
• The widest YoY moves for Net Income towards Common Stockholders: up 1300.47% in 2023, down 8939.54% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at -$526000.0 in 2022, then tumbled by 8939.54% to -$47.5 million in 2023, then jumped by 82.92% to -$8.1 million in 2024, then surged by 272.35% to $14.0 million in 2025, then jumped by 35.71% to $19.0 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $19.0 million in Q1 2026, $14.0 million in Q1 2025, and -$8.1 million in Q4 2024.